troleandomycin has been researched along with tetracycline in 21 studies
Studies (troleandomycin) | Trials (troleandomycin) | Recent Studies (post-2010) (troleandomycin) | Studies (tetracycline) | Trials (tetracycline) | Recent Studies (post-2010) (tetracycline) |
---|---|---|---|---|---|
569 | 26 | 23 | 21,524 | 977 | 3,656 |
Protein | Taxonomy | troleandomycin (IC50) | tetracycline (IC50) |
---|---|---|---|
90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | 22.4474 | |
heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | 22.4474 | |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 8.33 | |
30S ribosomal protein S6 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 4.58 | |
Alpha-synuclein | Homo sapiens (human) | 6.06 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 4.58 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 4.58 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 4.58 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (76.19) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (19.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Willcox, RR | 1 |
von Graevenitz, A | 1 |
Griffith, LJ | 1 |
Frisby, BR | 1 |
Betinová, M | 1 |
Druzhinina, EN; Suvorkina, DV | 1 |
Druzhinina, EN; Suborkina, DV; Tebiakina, AE | 1 |
Ichida, F; Inoue, K; Ishiwara, S; Tanabe, Y; Watanabe, K | 1 |
Ross, S | 1 |
Linnane, AW; Stewart, PR | 1 |
Gadzhiev, SA; Sheĭko, VZ | 1 |
Cafiero, F; Girelli, M | 1 |
Ishizaki, T; Zhao, XJ | 1 |
BHARGAVA, KB; DESA, JV | 1 |
JERVEY, L | 1 |
KATSU, M; NORMURA, K; OSUGA, H; YAMAMOTO, I | 1 |
ISENBERG, HD | 1 |
1 trial(s) available for troleandomycin and tetracycline
Article | Year |
---|---|
'Triple tetracycline' in the treatment of non-gonococcal urethritis in males.
Topics: Anti-Bacterial Agents; Chlortetracycline; Clinical Trials as Topic; Demeclocycline; England; Erythromycin; Humans; Leucomycins; Male; Tetracycline; Troleandomycin; Urethritis; Wales | 1972 |
20 other study(ies) available for troleandomycin and tetracycline
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Sensitivity studies on Serratia strains from clinical specimens.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriological Techniques; Cephalothin; Chloramphenicol; Colistin; Erythromycin; Furazolidone; Humans; Kanamycin; Nalidixic Acid; Neomycin; Nitrofurantoin; Nitrofurazone; Novobiocin; Penicillin G; Penicillin Resistance; Serratia marcescens; Streptomycin; Sulfadiazine; Tetracycline; Troleandomycin | 1967 |
Development of resistance to kanamycin.
Topics: Bacitracin; Chloramphenicol; Cloxacillin; Enterobacter; Erythromycin; Escherichia coli; Kanamycin; Methicillin; Neomycin; Novobiocin; Penicillin Resistance; Penicillins; Proteus; Pseudomonas aeruginosa; Staphylococcus; Tetracycline; Troleandomycin | 1966 |
A laboratory comparison of tri-acetyl oleandomycin and nine other antibiotics.
Topics: Anti-Bacterial Agents; Chloramphenicol; Clostridium; Cloxacillin; Enterococcus faecalis; Erythromycin; Haemophilus influenzae; Lincomycin; Novobiocin; Penicillin G; Penicillin Resistance; Staphylococcus; Streptococcus; Streptomycin; Tetracycline; Troleandomycin; Vancomycin | 1968 |
[Effect of tetracyclines, macrolide antibiotics, and sigmamycin on staphylococci in vitro].
Topics: Anti-Bacterial Agents; Chlortetracycline; Demeclocycline; Drug Resistance, Microbial; Erythromycin; Leucomycins; Oleandomycin; Oxytetracycline; Staphylococcus; Tetracycline; Troleandomycin | 1968 |
[Determination of the content of triacetyloleandomycin and tetracycline in dry suspensions of oletetrine by the agar diffusion method].
Topics: Agar; Bacillus cereus; Bacillus subtilis; Depression, Chemical; Immunodiffusion; Oleandomycin; Suspensions; Tetracycline; Troleandomycin | 1968 |
[Effect of oleandomycin in triacetyloleandomycin on the result of determination of biological activity of the latter by agar diffusion method].
Topics: Bacillus; Bacillus cereus; Bacteria; Drug Compounding; Drug Resistance, Microbial; Drug Storage; Drug Synergism; Immunodiffusion; Oleandomycin; Stimulation, Chemical; Tetracycline; Time Factors; Troleandomycin | 1970 |
[A case of cholestatic jaundice due to tetracycline-triacetyloleandomycin].
Topics: Cholestasis; Humans; Tetracycline; Troleandomycin | 1965 |
Staphylococcal infections in nurseries.
Topics: Ampicillin; Bacitracin; Cephalosporins; Chloramphenicol; Cross Infection; Erythromycin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin; Novobiocin; Penicillin G; Sepsis; Tetracycline; Troleandomycin; Vancomycin | 1966 |
The inhibition of chlorophyll formation in Euglena by antibiotics which inhibit bacterial and mitochondrial protein synthesis.
Topics: Chloramphenicol; Chlorophyll; Chloroplasts; Erythromycin; Euglena; Leucomycins; Lincomycin; Photosynthesis; Tetracycline; Troleandomycin | 1967 |
[Experience in the clinical application of sigmamycin (primarily in surgery of the lung, heart and esophagus)].
Topics: Adolescent; Adult; Aged; Cardiac Surgical Procedures; Child; Empyema; Esophageal Diseases; Extracorporeal Circulation; Female; Humans; Hypothermia, Induced; Inflammation; Infusions, Parenteral; Injections, Intravenous; Injections, Spinal; Lung Diseases; Male; Middle Aged; Pleura; Pleural Diseases; Postoperative Care; Suppuration; Tetracycline; Troleandomycin | 1967 |
[Clinico-therapeutic observations on a voluminous pulmonary abscess cured with medical treatment].
Topics: Gentamicins; Glucose; Humans; Lung Abscess; Male; Middle Aged; Penicillins; Streptomycin; Tetracycline; Troleandomycin; Vitamins | 1970 |
Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes.
Topics: Anti-Infective Agents; Antimalarials; Chromatography; Cytochrome P-450 Enzyme System; Doxycycline; Drug Interactions; Erythromycin; Humans; Hydroxylation; Ketoconazole; Microsomes, Liver; Nifedipine; Omeprazole; Primaquine; Quinine; Tetracycline; Troleandomycin | 1997 |
TRIACETYL OLEANDOMYCIN AND TETRACYCLINE COMBINATION IN OTORHINOLARYNGOLOGIC INFECTIONS.
Topics: Adolescent; Anti-Bacterial Agents; Bacillus; Child; Drug Resistance, Microbial; Humans; Oleandomycin; Otolaryngology; Penicillin Resistance; Penicillins; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Tetracycline; Toxicology; Troleandomycin | 1964 |
TRIACETYLOLEANDOMYCIN.
Topics: Anti-Bacterial Agents; Chloramphenicol; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Humans; Penicillins; Pharmacology; Pneumococcal Infections; Staphylococcal Infections; Streptococcal Infections; Tetracycline; Troleandomycin | 1964 |
[SUCESSFUL TREATMENT OF A CASE OF PNEUMOCOCCAL MENINGITIS WITH LONG-TERM COMBINED THERAPY OF ANTIBIOTICS AND ADRENAL CORTEX HORMONES].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Dexamethasone; Drug Therapy; Erythromycin; Humans; Meningitis; Meningitis, Pneumococcal; Penicillins; Prednisolone; Streptococcus pneumoniae; Streptomycin; Tetracycline; Troleandomycin | 1964 |
THE CONSISTENCY OF IN VITRO MICROBIAL RESPONSE: A SURVEY OF THE AMERICAS, EUROPE AND JAPAN.
Topics: Anti-Bacterial Agents; Bacteriophages; Chloramphenicol; Drug Resistance, Microbial; Erythromycin; Europe; Humans; In Vitro Techniques; Japan; Mexico; Penicillins; Pharmacology; South America; Staphylococcus; Streptococcus; Streptococcus pneumoniae; Tetracycline; Troleandomycin | 1965 |